← Mahindra Manulife Mutual Fund

Mahindra Manulife Innovation Opportunities Fund - Direct - Growth

Equity Data as of Jun 2026 Comparing May 2026 → Jun 2026
Share: WhatsApp X
Stocks Held
46
Jun 2026
Equity Holdings
₹199.42 Cr
Equity only, excl. debt & cash
Top 5 Weight
16.3%
Diversified
Top 10 Weight
29.6%
Diversified
Changes
46
0 new · 0 exits
Top Sector
Pharmaceuticals & Biotechnology
9.8% of portfolio
📋 What Happened This Month Among existing holdings, Axis Bank Limited saw the biggest increase — now at 3.02% of the portfolio. Acutaas Chemicals Ltd was trimmed the most, now at 2.65%. Eternal Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 9.8%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.
Sector Shift Industry allocation month-over-month
Apr 2026 May 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 10.7% 10.5% -0.1%
Banks 9.7% 9.1% -0.6%
Transport Services 6.9% 6.5% -0.4%
Auto Components 6.0% 5.8% -0.2%
IT - Software 5.2% 5.8% +0.6%
Retailing 6.0% 5.6% -0.4%
Electrical Equipment 4.9% 5.2% +0.3%
Healthcare Services 4.8% 4.9% +0.1%
Telecom - Services 4.5% 4.7% +0.2%
Finance 4.9% 4.6% -0.4%
May 2026 Jun 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 10.5% 9.8% -0.8%
Banks 9.1% 9.7% +0.6%
Transport Services 6.5% 6.8% +0.3%
Auto Components 5.8% 5.6% -0.2%
Retailing 5.6% 5.3% -0.2%
IT - Software 5.8% 5.2% -0.6%
Electrical Equipment 5.2% 4.9% -0.3%
Healthcare Services 4.9% 4.9% 0.0%
Finance 4.6% 4.8% +0.2%
Telecom - Services 4.7% 4.5% -0.2%
Biggest Add
Axis Bank Limited
+0.44% · now 3.02%
Biggest Trim
Acutaas Chemicals Ltd
-0.58% · now 2.65%

What Changed in the Portfolio This Month?

Comparing May 2026 → Jun 2026

May 2026 Jun 2026
↑ 15 Increased ↓ 31 Decreased
#StockSectorMay 2026Jun 2026Change
1
Axis Bank Limited
₹6.20 Cr
Banks 2.58% 3.02% +0.44%
2
InterGlobe Aviation Limited
₹5.85 Cr
Transport Services 2.47% 2.85% +0.38%
3
K.P.R. Mill Limited
₹4.67 Cr
Textiles & Apparels 1.98% 2.27% +0.29%
4
Torrent Pharmaceuticals Limited
₹4.20 Cr
Pharmaceuticals & Biotechnology 1.86% 2.05% +0.19%
5
Crompton Greaves Consumer Electricals Limited
₹3.10 Cr
Consumer Durables 1.32% 1.51% +0.19%
6
AIA Engineering Limited
₹5.00 Cr
Industrial Products 2.28% 2.43% +0.15%
7
Bajaj Finance Limited
₹6.49 Cr
Finance 3.02% 3.16% +0.14%
8
Radico Khaitan Limited
₹4.77 Cr
Beverages 2.19% 2.32% +0.13%
9
ICICI Bank Limited
₹6.98 Cr
Banks 3.29% 3.40% +0.11%
10
Belrise Industries Ltd.
₹4.16 Cr
Auto Components 1.95% 2.03% +0.08%
#StockSectorMay 2026Jun 2026Change
1
Acutaas Chemicals Ltd
₹5.46 Cr
Pharmaceuticals & Biotechnology 3.23% 2.65% -0.58%
2
Infosys Limited
₹2.91 Cr
IT - Software 1.74% 1.41% -0.33%
3
GE Vernova T&D India Limited
₹4.94 Cr
Electrical Equipment 2.65% 2.40% -0.25%
4
PB Fintech Limited
₹4.56 Cr
Financial Technology (Fintech) 2.46% 2.22% -0.24%
5
Reliance Industries Limited
₹5.72 Cr
Petroleum Products 3.01% 2.78% -0.23%
6
Tech Mahindra Limited
₹3.66 Cr
IT - Software 1.99% 1.78% -0.21%
7
Swiggy Limited
₹2.93 Cr
Retailing 1.63% 1.43% -0.20%
8
Tube Investments of India Limited
₹3.94 Cr
Auto Components 2.10% 1.92% -0.18%
9
Varun Beverages Limited
₹3.22 Cr
Beverages 1.73% 1.57% -0.16%
10
Divi's Laboratories Limited
₹4.11 Cr
Pharmaceuticals & Biotechnology 2.15% 2.00% -0.15%

What Stocks Does This Fund Hold?

46 stocks — Jun 2026

# Stock Sector Cap Weight & Value
1
₹8.04 Cr
Retailing
3.91%
2
₹6.98 Cr
Banks
3.40%
3
₹6.49 Cr
Finance
3.16%
4
₹6.20 Cr
Banks
3.02%
5
₹5.85 Cr
Transport Services
2.85%
6
₹5.72 Cr
Petroleum Products
2.78%
7
₹5.53 Cr
Construction
2.69%
8
₹5.46 Cr
Pharmaceuticals & Biotechnology
2.65%
9
₹5.28 Cr
Telecom - Services
2.57%
10
₹5.28 Cr
Healthcare Services
2.57%
🏆 Top stocks held by Equity funds
See which stocks all active Equity fund managers are buying — ranked by total value invested
🏦 Mahindra Manulife Mutual Fund — Portfolio & Holdings
See all funds managed by Mahindra Manulife Mutual Fund — conviction stocks, monthly entries & exits

Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.

Found a discrepancy or have feedback? Contact Us — we read every message personally.